Loading...
CBST logo

The Cannabist Company Holdings Inc.NEOE:CBST Stock Report

Market Cap CA$22.4m
Share Price
n/a
1Y-41.7%
7D0%
1D0%
Portfolio Value
View

The Cannabist Company Holdings Inc.

NEOE:CBST Stock Report

Market Cap: CA$22.4m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Cannabist Company Holdings (CBST) Stock Overview

The Cannabist Company Holdings Inc. cultivates, manufactures, and sells cannabis products and related services for the medical and adult-use markets in the United States and internationally. More details

CBST fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

CBST Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW497,905 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
AG
Agricola
497,905 investors already sharing narratives

The Cannabist Company Holdings Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Cannabist Company Holdings
Historical stock prices
Current Share PriceUS$0.035
52 Week HighUS$0.23
52 Week LowUS$0.03
Beta0.72
1 Month Change0%
3 Month Change0%
1 Year Change-41.67%
3 Year Change-94.53%
5 Year Change-99.40%
Change since IPO-99.46%

Recent News & Updates

Recent updates

Analysis Article Mar 31

What Does The Future Hold For Columbia Care Inc. (CSE:CCHW)? These Analysts Have Been Cutting Their Estimates

One thing we could say about the analysts on Columbia Care Inc. ( CSE:CCHW ) - they aren't optimistic, having just made...
Analysis Article Jan 24

Columbia Care (CSE:CCHW) Is Making Moderate Use Of Debt

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article Oct 02

Is Columbia Care (CSE:CCHW) Using Debt Sensibly?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Shareholder Returns

CBSTCA PharmaceuticalsCA Market
7D0%1.2%0.3%
1Y-41.7%43.0%29.2%

Return vs Industry: CBST underperformed the Canadian Pharmaceuticals industry which returned 59.8% over the past year.

Return vs Market: CBST underperformed the Canadian Market which returned 31.6% over the past year.

Price Volatility

Is CBST's price volatile compared to industry and market?
CBST volatility
CBST Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement9.9%
Market Average Movement9.6%
10% most volatile stocks in CA Market16.7%
10% least volatile stocks in CA Market3.6%

Stable Share Price: CBST's share price has been volatile over the past 3 months compared to the Canadian market.

Volatility Over Time: Insufficient data to determine CBST's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
20121,681David Hartwww.cannabistcompany.com

The Cannabist Company Holdings Inc. cultivates, manufactures, and sells cannabis products and related services for the medical and adult-use markets in the United States and internationally. The company operates medical and/or adult use marijuana businesses and dispensaries. It also offers flowers, concentrates, edibles, oils and tablets, and accessories under the dreamt, Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber brands.

The Cannabist Company Holdings Inc. Fundamentals Summary

How do Cannabist Company Holdings's earnings and revenue compare to its market cap?
CBST fundamental statistics
Market capCA$22.39m
Earnings (TTM)-CA$253.67m
Revenue (TTM)CA$495.89m
0.0x
P/S Ratio
-0.1x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CBST income statement (TTM)
RevenueUS$349.84m
Cost of RevenueUS$246.59m
Gross ProfitUS$103.25m
Other ExpensesUS$282.21m
Earnings-US$178.96m

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.33
Gross Margin29.51%
Net Profit Margin-51.15%
Debt/Equity Ratio-195.7%

How did CBST perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/20 11:53
End of Day Share Price 2026/03/23 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

The Cannabist Company Holdings Inc. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Aaron GreyAlliance Global Partners
Matt BottomleyCanaccord Genuity
Owen BennettJefferies LLC